Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): Results of an open-label, single-arm, multi-institutional, phase 2 trial

The Lancet Oncology

Volumn 16, Issue 15, 2015, Pages 1537-1546

  Garcia Aguilar, Julio ^a   Renfro, Lindsay A ^b   Chow, Oliver S ^a   Shi, Qian ^b   Carrero, Xiomara W ^b   Lynn, Patricio B ^a   Thomas, Charles R ^c   Chan, Emily ^d   Cataldo, Peter A ^e   Marcet, Jorge E ^f   Medich, David S ^g   Johnson, Craig S ^h   Oommen, Samuel C ⁱ   Wolff, Bruce G ^b   Pigazzi, Alessio ^j   McNevin, Shane M ^k   Pons, Roger K ^l   Bleday, Ronald ^m  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MAYO CLINIC   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF VERMONT   (United States)

^f TAMPA GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^h Saint Francis Hospital Tulsa   (United States)

ⁱ John Muir Medical Center   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k Holy Family Hospital   (United States)

^l Hialeah Hospital   (United States)

^m BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; OXALIPLATIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CANCER STAGING; CANCER SURGERY; CARDIOVASCULAR DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; ENDOCRINE DISEASE; EYE DISEASE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HUMAN; INFECTION; INTENTION TO TREAT ANALYSIS; KIDNEY DISEASE; LIVER DISEASE; LUNG DISEASE; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; OPEN STUDY; ORGAN PRESERVATION; PAIN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CANCER; RECTUM SURGERY; SEXUAL DYSFUNCTION; SINGLE BLIND PROCEDURE; SKIN DISEASE; UNSPECIFIED SIDE EFFECT; UROGENITAL TRACT DISEASE; ABDOMINAL SURGERY; ADENOCARCINOMA; ADJUVANT THERAPY; CHEMORADIOTHERAPY; CLINICAL TRIAL; CONSERVATIVE TREATMENT; MIDDLE AGED; PATHOLOGY; RECTAL NEOPLASMS; TIME; TREATMENT OUTCOME; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORGAN SPARING TREATMENTS; RECTAL NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84961058058     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(15)00215-6     Document Type: Article

References (35)

1. Heald RJ, Husband EM, Ryall RD The mesorectum in rectal cancer surgery-the clue to pelvic recurrence?. Br J Surg 1982, 69:613-616.
2. Paun BC, Cassie S, MacLean AR, Dixon E, Buie WD Postoperative complications following surgery for rectal cancer. Ann Surg 2010, 251:807-818.
3. Lange MM, van de Velde CJ Urinary and sexual dysfunction after rectal cancer treatment. NatRev Urol 2011, 8:51-57.
4. Floodeen H, Lindgren R, Hallbook O, Matthiessen P Evaluation of long-term anorectal function after low anterior resection: a 5-year follow-up of a randomized multicenter trial. Dis Colon Rectum 2014, 57:1162-1168.
5. Morson BC Factors influencing the prognosis of early cancer of the rectum. Proc R Soc Med 1966, 59:607-608.
6. Garcia-Aguilar J, Mellgren A, Sirivongs P, Buie D, MadoffRD, Rothenberger DA Local excision of rectal cancer without adjuvant therapy: a word of caution. Ann Surg 2000, 231:345-351.
7. Paty PB, Nash GM, Baron P, et al. Long-term results of local excision for rectal cancer. Ann Surg 2002, 236:522-530.
8. Madbouly KM, Remzi FH, Erkek BA, et al. Recurrence after transanal excision of T1 rectal cancer: should we be concerned?. Dis Colon Rectum 2005, 48:719-721.
9. Weiser MR, Landmann RG, Wong WD, et al. Surgical salvage of recurrent rectal cancer after transanal excision. Dis Colon Rectum 2005, 48:1169-1175.
10. Stipa F, Giaccaglia V, Burza A Management and outcome of local recurrence following transanal endoscopic microsurgery for rectal cancer. Dis Colon Rectum 2012, 55:262-269.
11. Friel CM, Cromwell JW, Marra C, MadoffRD, Rothenberger DA, Garcia-Aguilar J Salvage radical surgery after failed local excision for early rectal cancer. Dis Colon Rectum 2002, 45:875-879.
12. Mellgren A, Sirivongs P, Rothenberger DA, MadoffRD, Garcia-Aguilar J Is local excision adequate therapy for early rectal cancer?. Dis Colon Rectum 2000, 43:1064-1071.
13. You YN, Baxter NN, Stewart A, Nelson H Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. Ann Surg 2007, 245:726-733.
14. Stitzenberg KB, SanoffHK, Penn DC, Meyers MO, Tepper JE Practice patterns and long-term survival for early-stage rectal cancer. J Clin Oncol 2013, 31:4276-4282.
15. van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011, 12:575-582.
16. Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 2012, 30:1926-1933.
17. Borschitz T, Wachtlin D, Mohler M, Schmidberger H, Junginger T Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol 2008, 15:712-720.
18. Nair RM, Siegel EM, Chen DT, et al. Long-term results of transanal excision after neoadjuvant chemoradiation for T2 and T3 adenocarcinomas of the rectum. J Gastrointest Surg 2008, 12:1797-1806.
19. Kim CJ, Yeatman TJ, Coppola D, et al. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg 2001, 234:352-359.
20. Lezoche E, Baldarelli M, Lezoche G, Paganini AM, Gesuita R, Guerrieri M Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy. Br J Surg 2012, 99:1211-1218.
21. Garcia-Aguilar J, Shi Q, Thomas CR, et al. A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol 2012, 19:384-391.
22. Fleming TR, Harrington DP Counting processes and survival analysis 1991, Wiley John & Sons Ltd, London.
23. Rockwood TH, Church JM, Fleshman JW, et al. Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index. Dis Colon Rectum 1999, 42:1525-1532.
24. Ward WL, Hahn EA, Mo F, Hernandez L, Tulsky DS, Cella D Reliability and validity of the Functional assessment of cancer therapy-colorectal (FACT-C) quality of life instrument. Qual Life Res 1999, 8:181-195.
25. Steele GD, Herndon JE, Bleday R, et al. Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol 1999, 6:433-441.
26. Mann HBW, Donald R On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 1947, 18:50-60.
27. 2 from contingency tables, and the calculation of P. J R Stat Soc 1922, 85:87-94.
28. Aschele C, Cionini L, Lonardi S, et al. Primary tumour response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol 2011, 29:2773-2780.
29. Gerard JP, Azria D, Gourgou-Bourgade S, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 2010, 28:1638-1644.
30. O'Connell MJ, Colangelo LH, Beart RW, et al. Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04. J Clin Oncol 2014, 32:1927-1934.
31. Bonjer HJ, Deijen CL, Abis GA A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med 2015, 372:1324-1332. for the COLOR II Study Group.
32. Garcia-Aguilar J, Pollack J, Lee SH, et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum 2002, 45:10-15.
33. Landmann RG, Wong WD, HoepflJ, et al. Limitations of early rectal cancer nodal staging may explain failure after local excision. Dis Colon Rectum 2007, 50:1520-1525.
34. Fazio VW, Zutshi M, Remzi FH, et al. A randomized multicenter trial to compare long-term functional outcome, quality of life, and complications of surgical procedures for low rectal cancers. Ann Surg 2007, 246:481-490.
35. Russell MM, Ganz PA, Lopa S, et al. Comparative effectiveness of sphincter-sparing surgery versus abdominoperineal resection in rectal cancer: patient-reported outcomes in National Surgical Adjuvant Breast and Bowel Project randomized trial R-04. Ann Surg 2015, 261:144-148.